Praxis Precision Medicines, a clinical-stage biopharmaceutical company dedicated to developing therapies for complex central nervous system disorders, has made a significant financial move by announcing the pricing of its underwritten public offering, which is expected to generate gross proceeds of
A landmark study examining mental health care delivery for millions of Medicare beneficiaries has revealed that telehealth, once a temporary measure, has firmly established itself as a dominant and permanent fixture in the healthcare landscape, fundamentally reshaping how patients access services
Sevoflurane has long been a cornerstone of pediatric anesthesia, allowing millions of children to undergo necessary surgical procedures safely and without pain each year. Despite its widespread and effective use, a shadow of concern has emerged from preclinical research, where animal studies have
Intraventricular hemorrhage, a form of bleeding within the brain's delicate ventricles, represents one of the most significant threats to the long-term health and neurodevelopment of preterm infants. For decades, the standard of care has been largely reactive, identifying brain bleeds only after
The continued access to virtual medical care for millions of American seniors hangs precariously in the balance, subject to a legislative cycle of temporary extensions that introduces profound instability into the nation's healthcare system. Responding to this critical uncertainty, the American
The blueprint for a life-saving drug can often be found in the intricate, three-dimensional architecture of a single protein, yet viewing this structure with perfect clarity has remained a persistent challenge for modern science. For pharmaceutical researchers, this microscopic world is the
